TipRanks
BioMarin Pharmaceutical (MX:BMRN)
:BMRN
Mexico Market
BMRN
BioMarin Pharmaceutical
RESEARCH TOOLSreports

BioMarin Pharmaceutical (BMRN) Stock News & Sentiment

0 Followers
BioMarin ends VOXZOGO development for Noonan syndrome
Premium
Company Announcements
BioMarin ends VOXZOGO development for Noonan syndrome
4d ago
8K
BMRN
BioMarin Pharmaceutical Adds Independent Director to Board
Premium
Company Announcements
BioMarin Pharmaceutical Adds Independent Director to Board
5d ago
8K
BMRN
BioMarin: Neutral (Hold) Rating Reiterated as VOXZOGO Opportunity Balances YUVIWEL Competitive Risk; $60 Price Target Unchanged
Premium
Ratings
BioMarin: Neutral (Hold) Rating Reiterated as VOXZOGO Opportunity Balances YUVIWEL Competitive Risk; $60 Price Target Unchanged
9d ago
BMRN
BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics
Premium
Company Announcements
BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics
18d ago
8K
BMRN
Balanced Upside and Execution Risks Lead Richter to Maintain Hold on BioMarin After ASND Settlement and Voxzogo Expansion Plans
Premium
Ratings
Balanced Upside and Execution Risks Lead Richter to Maintain Hold on BioMarin After ASND Settlement and Voxzogo Expansion Plans
18d ago
BMRN
BioMarin Settlement with Ascendis Clears Legal Overhang; Analyst Reaffirms Buy Rating and Maintains $114 Price Target
Premium
Ratings
BioMarin Settlement with Ascendis Clears Legal Overhang; Analyst Reaffirms Buy Rating and Maintains $114 Price Target
18d ago
BMRN
BioMarin Kept at Hold as YUVIWEL Royalties Lift DCF and Price Target Rises from $59 to $60 Amid VOXZOGO Headwinds
Premium
Ratings
BioMarin Kept at Hold as YUVIWEL Royalties Lift DCF and Price Target Rises from $59 to $60 Amid VOXZOGO Headwinds
19d ago
BMRN
More MX:BMRN News >

BMRN News on the Web

BioMarin Pharmaceutical Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis
Insider Monkey
Bullish
BioMarin Pharmaceutical Inc. at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
BioMarin Pharmaceutical Inc. at Cantor Global Healthcare Conference Transcript
GuruFocus News
Neutral
BioMarin Pharmaceutical Inc. at Wells Fargo Healthcare Conference Transcript
GuruFocus News
Neutral
BioMarin Pharmaceutical Inc (BMRN) EVP and Chief Legal Officer George Davis Sells 17,557 Shares
GuruFocus News
Neutral
Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), BioMarin Pharmaceutical (BMRN) and Ionis Pharmaceuticals (IONS)
TipRanks News
Neutral
BioMarin Pharmaceutical Secures Global CNP Licensing Settlement
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MX:BMRN
Sector Average
Media Buzz
This Week11 articles
Weekly Average15.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:BMRN’s Media Buzz Sentiment?
11 articles about MX:BMRN were published this week. In an average week, 15.75 articles are published.
    What is MX:BMRN’s weekly average amount of articles?
    In an average week, 15.75 articles about MX:BMRN are published.
      What is MX:BMRN’s News Sentiment?
      100% of articles about MX:BMRN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        ASNDAscendis Pharma
        CRBPCorbus Pharmaceuticals
        RVMDRevolution Medicines
        BNTCBenitec Biopharma
        GNNSFGenscript Biotech
        Showing the stocks with the most bullish news sentiment over the past week